These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37975967)

  • 21. Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE
    Minasian LM; O'Mara A; Mitchell SA
    Patient Relat Outcome Meas; 2022; 13():249-258. PubMed ID: 36524232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linguistic validation of the simplified Chinese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™).
    Kkf C; Mitchell SA; Chan N; Ang E; Tam W; Kanesvaran R
    BMC Cancer; 2020 Nov; 20(1):1153. PubMed ID: 33243173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating the patient voice with clinician reports to identify a hepatocellular carcinoma-specific subset of treatment-related symptomatic adverse events.
    Speck RM; Lenderking WR; Shaw JW
    J Patient Rep Outcomes; 2017; 2():35. PubMed ID: 30175317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
    Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Arnold B; Mitchell SA; Lent L; Mendoza TR; Rogak LJ; Barragán NM; Willis G; Medina M; Lechner S; Penedo FJ; Harness JK; Basch EM;
    Support Care Cancer; 2016 Jul; 24(7):2843-51. PubMed ID: 26838022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.
    Veitch ZW; Shepshelovich D; Gallagher C; Wang L; Abdul Razak AR; Spreafico A; Bedard PL; Siu LL; Minasian L; Hansen AR
    J Natl Cancer Inst; 2021 Aug; 113(8):980-988. PubMed ID: 33616650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop.
    Kluetz PG; Kanapuru B; Lemery S; Johnson LL; Fiero MH; Arscott K; Barbachano Y; Basch E; Campbell M; Cappelleri JC; Cella D; Cleeland C; Coens C; Daniels S; Denlinger CS; Fairclough DL; Hillard JR; Minasian L; Mitchell SA; O'Connor D; Patel S; Rubin EH; Ryden A; Soltys K; Sridhara R; Thanarajasingam G; Velikova G; Coons SJ
    Value Health; 2018 Jun; 21(6):742-747. PubMed ID: 29909880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
    Mazza GL; Petersen MM; Ginos B; Langlais BT; Heon N; Gounder MM; Mahoney MR; Zoroufy AJ; Schwartz GK; Rogak LJ; Thanarajasingam G; Basch E; Dueck AC
    Qual Life Res; 2022 Apr; 31(4):1069-1080. PubMed ID: 34420143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.
    Reeve BB; McFatrich M; Pinheiro LC; Freyer DR; Basch EM; Baker JN; Withycombe JS; Sung L; Mack JW; Waldron MK; Mowbray C; Palma D; Hinds PS
    J Pain Symptom Manage; 2017 Apr; 53(4):759-766. PubMed ID: 28062347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology.
    Sandler KA; Mitchell SA; Basch E; Raldow AC; Steinberg ML; Sharif J; Cook RR; Kupelian PA; McCloskey SA
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):44-52. PubMed ID: 30102201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™).
    Hagelstein V; Ortland I; Wilmer A; Mitchell SA; Jaehde U
    Ann Oncol; 2016 Dec; 27(12):2294-2299. PubMed ID: 27681863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Japanese version of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events.
    Kawaguchi T; Azuma K; Sano M; Kim S; Kawahara Y; Sano Y; Shimodaira T; Ishibashi K; Miyaji T; Basch E; Yamaguchi T
    J Patient Rep Outcomes; 2017; 2(1):2. PubMed ID: 29757309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dutch translation and linguistic validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™).
    Veldhuijzen E; Walraven I; Mitchell SA; Moore EY; McKown SM; Lauritzen M; Kim KJ; Belderbos JSA; Aaronson NK
    J Patient Rep Outcomes; 2020 Oct; 4(1):81. PubMed ID: 33025309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections.
    Kim J; Singh H; Ayalew K; Borror K; Campbell M; Johnson LL; Karesh A; Khin NA; Less JR; Menikoff J; Minasian L; Mitchell SA; Papadopoulos EJ; Piekarz RL; Prohaska KA; Thompson S; Sridhara R; Pazdur R; Kluetz PG
    Clin Cancer Res; 2018 Apr; 24(8):1780-1784. PubMed ID: 29237718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Miyaji T; Iioka Y; Kuroda Y; Yamamoto D; Iwase S; Goto Y; Tsuboi M; Odagiri H; Tsubota Y; Kawaguchi T; Sakata N; Basch E; Yamaguchi T
    J Patient Rep Outcomes; 2017; 1(1):8. PubMed ID: 29757296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy.
    Christiansen MG; Pappot H; Jensen PT; Mirza MR; Jarden M; Piil K
    J Patient Rep Outcomes; 2023 Jul; 7(1):72. PubMed ID: 37462855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linguistic Validation of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Korean.
    Cho J; Yoon J; Kim Y; Oh D; Kim SJ; Ahn J; Suh GY; Nam SJ; Mitchell SA
    J Glob Oncol; 2019 Mar; 5():1-10. PubMed ID: 30917069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective.
    Murugappan MN; King-Kallimanis BL; Reaman GH; Bhatnagar V; Horodniceanu EG; Bouchkouj N; Kluetz PG
    J Natl Cancer Inst; 2022 Jan; 114(1):12-19. PubMed ID: 33930159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data.
    Langlais B; Mazza GL; Thanarajasingam G; Rogak LJ; Ginos B; Heon N; Scher HI; Schwab G; Ganz PA; Basch E; Dueck AC
    J Pain Symptom Manage; 2022 Feb; 63(2):311-320. PubMed ID: 34371138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501).
    Snyder RA; Dueck AC; Fruth B; Shi Q; Hubbard JM; Herman JM; O'Reilly EM; Katz MHG
    Ann Surg; 2023 Oct; 278(4):598-608. PubMed ID: 37334719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.